EAM Global Investors LLC acquired a new position in shares of Inspire Medical Systems (NASDAQ:INSP) during the second quarter, HoldingsChannel reports. The fund acquired 31,695 shares of the company’s stock, valued at approximately $1,130,000.

A number of other institutional investors and hedge funds also recently modified their holdings of INSP. Wasatch Advisors Inc. purchased a new stake in Inspire Medical Systems during the 2nd quarter worth about $1,065,000. Sei Investments Co. purchased a new stake in Inspire Medical Systems during the 2nd quarter worth about $1,093,000. Jennison Associates LLC purchased a new stake in Inspire Medical Systems during the 2nd quarter worth about $3,185,000. EAM Investors LLC purchased a new stake in Inspire Medical Systems during the 2nd quarter worth about $3,661,000. Finally, Hodges Capital Management Inc. purchased a new stake in Inspire Medical Systems during the 2nd quarter worth about $4,176,000.

A number of analysts recently issued reports on the company. Zacks Investment Research cut Inspire Medical Systems from a “buy” rating to a “hold” rating in a report on Thursday. Stifel Nicolaus assumed coverage on Inspire Medical Systems in a report on Tuesday, May 29th. They set a “buy” rating and a $42.00 price objective on the stock. Guggenheim assumed coverage on Inspire Medical Systems in a report on Tuesday, May 29th. They set a “buy” rating and a $40.00 price objective on the stock. Goldman Sachs Group assumed coverage on Inspire Medical Systems in a report on Tuesday, May 29th. They set a “neutral” rating and a $25.00 price objective on the stock. Finally, Bank of America assumed coverage on Inspire Medical Systems in a report on Tuesday, May 29th. They set a “neutral” rating and a $36.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Inspire Medical Systems presently has an average rating of “Buy” and a consensus price target of $38.17.

Shares of INSP opened at $46.33 on Friday. Inspire Medical Systems has a 52-week low of $22.50 and a 52-week high of $50.00.

Inspire Medical Systems (NASDAQ:INSP) last announced its earnings results on Tuesday, August 7th. The company reported ($0.43) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.08. The business had revenue of $10.94 million during the quarter, compared to the consensus estimate of $9.30 million.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Recommended Story: Trading Strategy

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems (NASDAQ:INSP).

Institutional Ownership by Quarter for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.